Royce & Associates’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-75,267
| Closed | -$5.42M | – | 1100 |
|
|
2020
Q4 | $5.42M | Sell |
75,267
-179,211
| -70% | -$9.38M | 0.04% | 528 |
|
|
2020
Q3 | $11.6M | Buy |
254,478
+13,064
| +5% | +$546K | 0.13% | 244 |
|
|
2020
Q2 | $10.9M | Sell |
241,414
-8,865
| -4% | -$397K | 0.12% | 239 |
|
|
2020
Q1 | $9.64M | Sell |
250,279
-67,500
| -21% | -$3.11M | 0.13% | 209 |
|
|
2019
Q4 | $14.7M | Buy |
317,779
+55,000
| +21% | +$2.38M | 0.13% | 216 |
|
|
2019
Q3 | $10.7M | Buy |
262,779
+220,500
| +522% | +$9.52M | 0.1% | 295 |
|
|
2019
Q2 | $2.04M | Buy |
42,279
+25,000
| +145% | +$1.31M | 0.02% | 720 |
|
|
2019
Q1 | $1.08M | Sell |
17,279
-17,021
| -50% | -$1.17M | 0.01% | 848 |
|
|
2018
Q4 | $2.05M | Sell |
34,300
-13,400
| -28% | -$805K | 0.02% | 725 |
|
|
2018
Q3 | $3.07M | Hold |
47,700
| – | – | 0.02% | 720 |
|
|
2018
Q2 | $2.15M | Hold |
47,700
| – | – | 0.01% | 820 |
|
|
2018
Q1 | $1.48M | Sell |
47,700
-143,691
| -75% | -$4.73M | 0.01% | 910 |
|
|
2017
Q4 | $5.72M | Hold |
191,391
| – | – | 0.04% | 541 |
|
|
2017
Q3 | $6.32M | Buy |
191,391
+13,982
| +8% | +$484K | 0.04% | 516 |
|
|
2017
Q2 | $5.93M | Sell |
177,409
-35,000
| -16% | -$1.04M | 0.04% | 539 |
|
|
2017
Q1 | $6.15M | Sell |
212,409
-107,000
| -33% | -$2.65M | 0.04% | 517 |
|
|
2016
Q4 | $7.14M | Sell |
319,409
-157,291
| -33% | -$3.08M | 0.05% | 477 |
|
|
2016
Q3 | $8.85M | Sell |
476,700
-60,000
| -11% | -$1.13M | 0.06% | 413 |
|
|
2016
Q2 | $8.75M | Sell |
536,700
-70,000
| -12% | -$1.03M | 0.06% | 421 |
|
|
2016
Q1 | $7.09M | Hold |
606,700
| – | – | 0.04% | 496 |
|
|
2015
Q4 | $7.09M | Buy |
606,700
+306,700
| +102% | +$3.88M | 0.04% | 519 |
|
|
2015
Q3 | $3.67M | Buy |
+300,000
| New | +$3.82M | 0.02% | 723 |
|
Other funds holding BEAT
Royce & Associates's BEAT Position: Q1 2021 in Review
Royce & Associates sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 75,267 shares — an estimated $5.42M sold.
Royce & Associates first reported a position in BEAT in Q3 2015 and held it in 22 quarters. The position peaked at $14.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Royce & Associates reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Royce & Associates sold 75,267 BioTelemetry, Inc. shares in Q1 2021, an estimated $5.42M.
- Royce & Associates first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 22 quarters.
- Royce & Associates's BioTelemetry, Inc. position peaked at $14.7M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.